Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery

Phase 4

Withdrawn

Conditions: Nail Diseases

Interventions: Device: Hydrophilic polymer and potassium ferrate powder

First Posted Date: 2020-05-12

Last Posted Date: 2022-08-23

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04384679

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Radiation: 600cGY x 5 fractions

First Posted Date: 2020-05-01

Last Posted Date: 2024-03-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 60

Registration Number: NCT04371913

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York Presbyterian Hospital - Queens, New York, New York, United States
🇺🇸
New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States

Case Studies: Promoting Strategy Use in Functional Activities

Not Applicable

Completed

Conditions: Executive Dysfunction
Acquired Brain Injury
Cognitive Impairment

Interventions: Other: Multicontext (MC) approach

First Posted Date: 2020-04-27

Last Posted Date: 2020-04-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 8

Registration Number: NCT04363645

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache

Phase 1

Withdrawn

Conditions: Chronic Migraine
Cluster Headache
Trigeminal Neuralgia

Interventions: Drug: Ketorolac
Drug: Dexamethasone

First Posted Date: 2020-04-20

Last Posted Date: 2020-08-04

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04353505

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

After Cesarean Time Interval for Exercise (ACTIVE) Trial

Not Applicable

Active, not recruiting

Conditions: Postoperative Complications

Interventions: Behavioral: Structured exercise

First Posted Date: 2020-04-14

Last Posted Date: 2024-07-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT04345757

Locations: 🇺🇸
New York Presbyterian Hospital Weill Cornell, New York, New York, United States

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Phase 1

Recruiting

Conditions: Glioma

Interventions: Drug: 18F-FMISO PET
Drug: 18F-FLT PET

First Posted Date: 2020-03-16

Last Posted Date: 2024-03-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 30

Registration Number: NCT04309552

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

Phase 2

Recruiting

Conditions: Relapse Multiple Myeloma
Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Drug: Daratumumab SC
Drug: Clarithromycin
Drug: Pomalidomide
Drug: Dexamethasone

First Posted Date: 2020-03-10

Last Posted Date: 2024-06-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 40

Registration Number: NCT04302324

Locations: 🇺🇸
Weill Cornell Medicine - Multiple Myeloma Center, New York, New York, United States

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

Phase 3

Active, not recruiting

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Drug: N-acetyl cysteine
Drug: Placebo

First Posted Date: 2020-03-09

Last Posted Date: 2024-12-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 202

Registration Number: NCT04300920

Locations: 🇺🇸
Piedmont Healthcare, Austell, Georgia, United States
🇺🇸
Loyola University, Maywood, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

and more 22 locations

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Phase 2

Not yet recruiting

Conditions: Meningioma

Interventions: Drug: Ga-68- DOTATATE
Drug: Ga-68-DOTATOC

First Posted Date: 2020-03-06

Last Posted Date: 2024-11-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 6

Registration Number: NCT04298541

Locations: 🇺🇸
Weill Cornell Medical College of Cornell University, New York, New York, United States

Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region

Not Applicable

Completed

Conditions: TMJ Disorder
Myofacial Pain
TMD

Interventions: Other: CBD Oil
Other: Hemp Oil

First Posted Date: 2020-03-06

Last Posted Date: 2023-03-14

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 59

Registration Number: NCT04298554

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy